Condition: Acute Ischemic Stroke · Sponsor: LCMC Health
This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy, frequency of neurological deterioration or complications (seizure, hemorrhage, brain edema), and functional communication, activities of daily living (ADLs) and mobility.
This description comes directly from the study's public registry record.
Lawrence Matarutse · 504-962-6419 · Lawrence.Matarutse@lcmchealth.org
Sheryl Martin-Schild, MD, PhD · 504-982-3278 · sheryl.martin-schild@lcmchealth.org
Always discuss trial participation with your own doctor first.
| Touro Infirmary New Orleans | New Orleans, Louisiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06148285